Venus Remedies Limited, a leading pharmaceutical company, announced that its Board of Directors has approved the establishment of a wholly owned subsidiary in Hungary. This strategic move will be executed through its wholly owned German subsidiary, Venus Pharma GmbH, and aims to strengthen the company’s market presence in Eastern Europe.
The decision, made during a board meeting held on November 29, 2024, marks a significant step in Venus Remedies’ ongoing expansion strategy. By setting up operations in Hungary, the company intends to tap into the growing opportunities in Eastern European markets, enhancing its global footprint.
The establishment of the Hungarian subsidiary aligns with Venus Remedies’ vision of delivering world-class pharmaceutical products to a broader customer base while catering to the specific needs of the European healthcare market.
